Maudsley Prescribing Guideline 17+

Name: Maudsley Prescribing Guideline
Author: Skyscape Medpresso Inc

Skyscape Medpresso Inc

- Gratis
- Tilbyder køb i appen

Beskrivelse

"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.

The Maudsley Prescribing Guidelines in Psychiatry provides up-to-date information, expert guidance on prescribing practice in mental health, including drug choice, treatment of adverse effects and how to augment or switch medications. The text covers a wide range of topics including pharmacological interventions for schizophrenia, bipolar disorder, depression and anxiety, and many other less common conditions. There is advice on prescribing in children and adolescents, in substance misuse and in special patient groups.

This world-renowned guide has been written in concise terms by an expert team of psychiatrists and specialist pharmacists. The Guidelines help with complex prescribing problems and include information on prescribing psychotropic medications outside their licensed indications as well as potential interactions with other medications and substances such as alcohol, tobacco and caffeine. In addition, each of the 165 sections features a full reference list so that evidence on which guidance is based can be readily accessed.

KEY FEATURES:

- Is the world’s leading clinical resource for evidence-based prescribing in day-to-day clinical practice and for formulating prescribing policy
- Includes referenced information on topics such as transferring from one medication to another, prescribing psychotropic medications during pregnancy or breastfeeding, and treating patients with comorbid physical conditions, including impaired renal or hepatic function.
- Presents guidance on complex clinical problems that may not be encountered routinely
- Written for psychiatrists, neuropharmacologists, pharmacists, and clinical psychologists as well as nurses and medical trainees, The Maudsley Prescribing Guidelines in Psychiatry are the established reference source for ensuring the safe and effective use of medications for patients presenting with mental health problems.

ISBN 10: 1119442605

ISBN 13: 978-1119442608

SUBSCRIPTION :

Please purchase a yearly auto-renewing subscription to receive content access and continuous updates. Your subscription automatically renews every year, so you always have the latest content.

Yearly auto-renewing payments- $79.99

Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.

If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000

Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx

Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx

Author(s): David M. Taylor, Thomas R. E. Barnes, Allan H. Young
Publisher: John Wiley & Son Inc. and its affiliates

Psychiatry Pres. Guide 1/Y Sub

Guidance-prescribing practice-mental health

349,00 kr

Udvikleren, Skyscape Medpresso Inc, har angivet, at fremgangsmåder vedrørende app-anonymitet muligvis inkluderer håndtering af data som beskrevet nedenfor. Du kan få flere oplysninger her: udviklerens anonymitetspolitik.

Data, der ikke er tilknyttet dig

Følgende data vil muligvis blive indsamlet, men de er ikke tilknyttet din identitet:

Køb
Brugerindhold
Søgehistorik
Id'er
Brugsdata
Diagnostik

Fremgangsmåder vedrørende anonymitet kan variere, f.eks. baseret på de funktioner, du bruger, eller din alder. Læs mere

Oplysninger

Leverandør

Skyscape Medpresso Inc har identificeret sig selv som en forhandler af denne app og har bekræftet, at produktet eller tjenesten er i overensstemmelse med EU-lovgivning.

DUNS-nummer: 078854225
Adresse: 11 Apex Drive Suite 300A Marlborough Massachusetts 01752 USA
Telefonnummer: +1 5089512999
E-mail: developer@skyscape.com

Størrelse

11,3 MB

Kategori

Medicinsk

Kompatibilitet